Loudi City Central Hospital, Loudi, 417000 Hunan, China.
Hunan University of Medicine, Huaihua, 418000 Hunan, China.
Biomed Res Int. 2021 Nov 17;2021:7739628. doi: 10.1155/2021/7739628. eCollection 2021.
To know the clinical value of mammotome-assisted minimally invasive resection (MAMIR) in the treatment of patients with breast neoplasm, we performed a retrospective clinical study for the patients treated with the MAMIR and conventional open resection (COR).
Postoperative complications were compared between 40 patients treated with the MAMIR and 40 patients treated with the COR. The postoperative complications mainly included intraoperative blood loss, hospitalization days, operative time, surgical scar, and incidence of postoperative complications.
We found that the amount of intraoperative blood loss, hospitalization days, operative time, surgical scar, and incidence of postoperative complications in the MAMIR group were significantly lower than those of patients in the COR group.
Our results indicated that patients with breast neoplasm treated with the MAMIR had better outcomes, which reinforced the advantage of this approach.
为了了解乳腺微创旋切术(MAMIR)在治疗乳腺肿瘤患者中的临床价值,我们对接受 MAMIR 和传统开放性切除术(COR)治疗的患者进行了回顾性临床研究。
比较了 40 例接受 MAMIR 治疗的患者和 40 例接受 COR 治疗的患者的术后并发症。术后并发症主要包括术中出血量、住院天数、手术时间、手术瘢痕和术后并发症发生率。
我们发现 MAMIR 组的术中出血量、住院天数、手术时间、手术瘢痕和术后并发症发生率明显低于 COR 组。
我们的结果表明,接受 MAMIR 治疗的乳腺肿瘤患者的预后更好,这进一步证实了这种方法的优势。